rs6086350

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015192.4(PLCB1):​c.99+8T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0414 in 1,598,996 control chromosomes in the GnomAD database, including 1,616 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.043 ( 164 hom., cov: 32)
Exomes 𝑓: 0.041 ( 1452 hom. )

Consequence

PLCB1
NM_015192.4 splice_region, intron

Scores

2
Splicing: ADA: 0.0001641
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.06

Publications

5 publications found
Variant links:
Genes affected
PLCB1 (HGNC:15917): (phospholipase C beta 1) The protein encoded by this gene catalyzes the formation of inositol 1,4,5-trisphosphate and diacylglycerol from phosphatidylinositol 4,5-bisphosphate. This reaction uses calcium as a cofactor and plays an important role in the intracellular transduction of many extracellular signals. This gene is activated by two G-protein alpha subunits, alpha-q and alpha-11. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
PLCB1 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 12
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 20-8132758-T-C is Benign according to our data. Variant chr20-8132758-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 129917.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0757 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLCB1NM_015192.4 linkc.99+8T>C splice_region_variant, intron_variant Intron 1 of 31 ENST00000338037.11 NP_056007.1 Q9NQ66-1
PLCB1NM_182734.3 linkc.99+8T>C splice_region_variant, intron_variant Intron 1 of 32 NP_877398.1 Q9NQ66-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLCB1ENST00000338037.11 linkc.99+8T>C splice_region_variant, intron_variant Intron 1 of 31 1 NM_015192.4 ENSP00000338185.6 Q9NQ66-1

Frequencies

GnomAD3 genomes
AF:
0.0428
AC:
6506
AN:
151996
Hom.:
164
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0447
Gnomad AMI
AF:
0.0450
Gnomad AMR
AF:
0.0495
Gnomad ASJ
AF:
0.0893
Gnomad EAS
AF:
0.000389
Gnomad SAS
AF:
0.0211
Gnomad FIN
AF:
0.0176
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.0458
Gnomad OTH
AF:
0.0542
GnomAD2 exomes
AF:
0.0395
AC:
9656
AN:
244594
AF XY:
0.0393
show subpopulations
Gnomad AFR exome
AF:
0.0468
Gnomad AMR exome
AF:
0.0366
Gnomad ASJ exome
AF:
0.0985
Gnomad EAS exome
AF:
0.000165
Gnomad FIN exome
AF:
0.0208
Gnomad NFE exome
AF:
0.0468
Gnomad OTH exome
AF:
0.0543
GnomAD4 exome
AF:
0.0412
AC:
59623
AN:
1446888
Hom.:
1452
Cov.:
27
AF XY:
0.0410
AC XY:
29533
AN XY:
720626
show subpopulations
African (AFR)
AF:
0.0447
AC:
1478
AN:
33096
American (AMR)
AF:
0.0388
AC:
1729
AN:
44520
Ashkenazi Jewish (ASJ)
AF:
0.0971
AC:
2520
AN:
25948
East Asian (EAS)
AF:
0.0000506
AC:
2
AN:
39540
South Asian (SAS)
AF:
0.0252
AC:
2164
AN:
85714
European-Finnish (FIN)
AF:
0.0228
AC:
1209
AN:
53046
Middle Eastern (MID)
AF:
0.0818
AC:
468
AN:
5718
European-Non Finnish (NFE)
AF:
0.0429
AC:
47220
AN:
1099452
Other (OTH)
AF:
0.0473
AC:
2833
AN:
59854
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
2835
5670
8505
11340
14175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1716
3432
5148
6864
8580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0428
AC:
6508
AN:
152108
Hom.:
164
Cov.:
32
AF XY:
0.0413
AC XY:
3074
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.0447
AC:
1857
AN:
41508
American (AMR)
AF:
0.0494
AC:
755
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0893
AC:
310
AN:
3470
East Asian (EAS)
AF:
0.000390
AC:
2
AN:
5124
South Asian (SAS)
AF:
0.0211
AC:
102
AN:
4832
European-Finnish (FIN)
AF:
0.0176
AC:
187
AN:
10596
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.0458
AC:
3111
AN:
67968
Other (OTH)
AF:
0.0532
AC:
112
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
340
679
1019
1358
1698
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0483
Hom.:
150
Bravo
AF:
0.0456
Asia WGS
AF:
0.0140
AC:
50
AN:
3476

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 18, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 23, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 01, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Early Infantile Epileptic Encephalopathy, Autosomal Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 12 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
8.2
DANN
Benign
0.82
PhyloP100
-1.1
PromoterAI
0.048
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00016
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6086350; hg19: chr20-8113405; API